22 January 2014

The shrill row that erupted last week over the pharmaceutical industry’s apparent attempts to influence the government’s draft intellectual property (IP) policy may look like a storm in a tea-cup, but the reforms proposed by the government pose a very real threat to the global pharmaceutical industry’s operations in South Africa.

Read article HERE